UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
ITT CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Indiana
|
|
1-5672
|
|
13-5158950 |
|
|
|
|
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.) |
|
|
|
1133 Westchester Avenue
White Plains, New York
|
|
10604 |
|
|
|
(Address of principal executive offices)
|
|
(Zip Code) |
(914) 641-2000
(Registrant’s telephone number, including area code)
NOT APPLICABLE
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of
the registrant under any of the following provisions (see General Instruction A.2. below):
|
|
|
o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 1.01 Entry into a Material Definitive Agreement.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet
Arrangement of a Registrant.
Exelis Inc. and Xylem Inc. Senior Notes Offerings.
On
September 20, 2011, ITT Corporation (the
“Company”) and Exelis Inc. (
“Exelis”), a wholly-owned
subsidiary of
the Company, entered into an
indenture (the
“Exelis Indenture”) with Union Bank, N.A., as trustee
(the
“Trustee”),
relating to the issuance by Exelis of $250 million aggregate principal amount of 4.250% senior
notes due 2016 (the
“Exelis 2016 Notes”) and $400 million aggregate principal amount of 5.550% senior notes due 2021
(the
“Exelis
2021 Notes” and, together with the Exelis 2016 Notes, the
“Exelis Notes”) in a private placement to
qualified
institutional buyers pursuant to Rule 144A under the U.S. Securities Act of 1933, as amended (the
“Securities Act”).
On
September 20, 2011,
the Company and Xylem Inc. (
“Xylem”), a wholly-owned subsidiary of the
Company,
entered into an
indenture (the
“Xylem Indenture” and, together with the Exelis
Indenture, the
“Indentures”) with the
Trustee, relating to the issuance by Xylem of $600 million aggregate principal amount of 3.550%
senior notes due
2016 (the
“Xylem 2016 Notes”) and $600 million aggregate principal amount of 4.875% senior notes
due 2021 (the
“Xylem 2021 Notes” and, together with the Xylem 2016 Notes, the
“Xylem Notes”) in a private
placement to
qualified institutional buyers pursuant to Rule 144A under the Securities Act. The Exelis Notes and
the Xylem
Notes are hereinafter referred to collectively as the
“Notes.”
The Exelis 2016 Notes bear interest at a rate of 4.250% per annum and the Exelis 2021 Notes bear
interest at a rate
5.550% per annum. The Xylem 2016 Notes bear interest at a rate of 3.550% per annum and the Xylem
2021 Notes
bear interest at a rate of 4.875% per annum. Interest on the Notes accrues from
September 20, 2011.
Interest on the
Exelis Notes and the Xylem 2021 Notes is payable on April 1 and October 1 of each year, commencing
on
April 1,
2012. Interest on the Xylem 2016 Notes is payable on March 20 and September 20 of each year,
commencing on
March 20, 2012. The Exelis 2016 Notes will mature on
October 1, 2016 and the Xylem 2016 Notes will
mature on
September 20, 2016. The Exelis 2021 Notes and the Xylem 2021 Notes will mature on
October 1, 2021.
The Notes are initially guaranteed on a senior unsecured basis by
the Company. The guarantee will
terminate and
be automatically and unconditionally released upon the distribution of the common stock of Exelis
and Xylem to the
holders of
the Company’s common stock in connection with the previously announced spin-off of each
of Exelis and
Xylem from
the Company.
The public offering price of the Notes was (i) 99.824% of the principal amount of the Exelis 2016
Notes, (ii)
99.762% of the principal amount of the Exelis 2021 Notes; (iii) 99.809% of the principal amount of
the Xylem 2016
Notes; and (iv) 99.935% of the principal amount of the Xylem 2021 Notes. Exelis intends to use the
net proceeds
received from the offering of the Exelis Notes to pay a portion of a special cash distribution to
the Company and for
general corporate purposes. Xylem intends to use the net proceeds received from the offering of the
Xylem Notes
to pay a special cash distribution to
the Company, to fund its acquisition of YSI Incorporated,
which closed on
September 1, 2011, and for general corporate purposes.
The Company intends to use a portion of the
net proceeds
from the distributions to repay a portion of its outstanding indebtedness.
The
Indentures include covenants which restrict the ability of each of Exelis and Xylem, subject to
exceptions, to
incur debt secured by liens and engage in sale and lease-back transactions. The
Indentures also
provide for
customary events of default (subject, in certain cases, to receipt of notice of default and/or
customary grace and cure
periods), including but not limited to, (i) failure to pay interest for 30 days, (ii) failure to
pay principal when due,
(iii) failure to perform any other covenant in the
Indenture for 90 days after receipt of notice
from the trustee or from
holders of 25% of the outstanding principal amount and (iv) certain events of bankruptcy,
insolvency or
reorganization of each of Exelis and Xylem. Each of Exelis and Xylem, as the case may be, may
redeem each series
of the Exelis Notes or the Xylem Notes, as applicable, in whole or in part, at any time at a
redemption price equal to
the principal amount of the Exelis Notes or the Xylem Notes, as applicable, to be redeemed, plus a
make-whole
premium. If a change of control triggering event occurs, as defined in the
Indentures, each of
Exelis or Xylem will
be required to make an offer to purchase the Exelis Notes or the Xylem Notes, as applicable, at a
price equal to
101% of their principal amount plus accrued and unpaid interest to the date of repurchase.
Purchase Agreements
The Exelis Notes were offered and sold pursuant to a Purchase Agreement (the
“Exelis Purchase
Agreement”) dated
September 15, 2011, between
the Company, Exelis and Barclays Capital Inc., Citigroup Global Markets
Inc. and
J.P. Morgan Securities LLC, as representatives of the several initial purchasers named therein (the
“Exelis Initial
Purchasers”). The Xylem Notes were offered and sold pursuant to a Purchase Agreement (the
“Xylem
Purchase
Agreement”) dated
September 15, 2011, between
the Company, Xylem and J.P. Morgan Securities LLC,
RBS
Securities Inc. and Wells Fargo Securities, LLC, as representatives of the several initial
purchasers named therein
(the
“Xylem Initial Purchasers”).
On
September 20, 2011,
the Company and Exelis entered into a registration
rights agreement with the
Exelis Initial
Purchasers with respect to the Exelis Notes (the
“Exelis Registration Rights Agreement”) and the
Company and
Xylem entered into a registration
rights agreement with the Xylem Initial Purchasers with respect
to the Xylem
Notes (the
“Xylem Registration Rights Agreement”).
The Company and Exelis agreed under the Exelis
Registration
Rights Agreement, and
the Company and Xylem agreed under the Xylem Registration
Rights Agreement,
to (i) file
a registration statement on an appropriate registration form with respect to a registered offer to
exchange the Exelis
Notes or Xylem Notes, as applicable, for new notes, with terms substantially identical in all
material respects to the
Exelis Notes or Xylem Notes, as applicable, and (ii) cause the registration statement to be
declared effective under
the Securities Act.
If the exchange offer is not completed within 365 days after the issue date of the Notes or, if
required, Exelis and
Xylem, as applicable, will use its reasonable best efforts to file and to have declared effective a
shelf registration
statement relating to the resales of the Exelis Notes and Xylem Notes, as applicable.
If Exelis or Xylem fails to satisfy this obligation (a
“registration default”) under the Exelis
Registration Rights
Agreement or Xylem Registration
Rights Agreement, respectively, the annual interest rate on the
Exelis Notes and
Xylem Notes, as applicable, will increase by 0.25%. The annual interest rate on the Exelis Notes
and Xylem Notes,
as applicable, will increase by an additional 0.25% for each subsequent 90-day period during which
the registration
default continues, up to a maximum additional interest rate of 1.00% per year. If the registration
default is
corrected, the applicable interest rate on such Exelis Notes or Xylem Notes, as applicable, will
revert to the original
level.
If Exelis or Xylem must pay additional interest, Exelis or Xylem will pay it to the holders of the
Exelis Notes or the
Xylem Notes, as applicable, in cash on the same dates that it makes other interest payments on the
Exelis Notes and
Xylem Notes, as applicable, until the registration default is corrected.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
|
|
|
4.1
|
|
Indenture, dated as of September 20, 2011, between Exelis Inc., ITT Corporation, as guarantor,
and Union Bank, N.A., as trustee. |
|
4.2
|
|
Indenture, dated as of September 20, 2011, between Xylem Inc., ITT Corporation, as guarantor,
and Union Bank, N.A., as trustee. |
|
4.3
|
|
Form of Exelis Inc. 4.250% Senior Notes due 2016 |
|
4.4
|
|
Form of Exelis Inc. 5.550% Senior Notes due 2021 |
|
4.5
|
|
Form of Xylem Inc. 3.550% Senior Notes due 2016 |
|
4.6
|
|
Form of Xylem Inc. 4.875% Senior Notes due 2021 |